Background illustration for clinical trials search

Paid Clinical Trials Salem

Discover 951 paid clinical trials in Salem, Oregon. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors

for
Lung Cancer, Breast Cancer
Location: Portland OR, Seattle WA, Edmonton, Irving TX,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT06618287

Phase1, Phase2, Recruiting

PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III

for
Heart Failure NYHA Class II, Heart Failure NYHA Class III,
Location: Portland OR, Everett WA, San Francisco CA,
Sponsor: Endotronix, Inc.

Sex: All

Age: 18+

Code: NCT05934487

Recruiting

Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER

for
Endometrial Cancer
Location: Portland OR, Seattle WA, Victoria, Vancouver, Kelowna,
Sponsor: Canadian Cancer Trials Group

Sex: Female

Age: 18+

Code: NCT05640999

Phase2, Recruiting

Tailoring Therapy in Post-surgical Patients With Low-risk Endometrial Cancer

for
Stage I Uterine Corpus Endometrial Stromal Sarcoma AJCC v8,
Location: Portland OR, Issaquah WA, Seattle WA, Edmonds WA,
Sponsor: NRG Oncology

Sex: Female

Age: 18+

Code: NCT06388018

Phase2, Recruiting

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

for
Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8,
Location: Portland OR, Issaquah WA, Seattle WA, Edmonds WA,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06498635

Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Two Year Developmental Follow-up for PREMOD2 Trial (Premature Infants Receiving Milking or Delayed Cord Clamping)

for
Neurodevelopmental Abnormality
Location: Portland OR, Salt Lake City UT, Edmonton,
Sponsor: Sharp HealthCare

Sex: All

Age: 1 - 3

Code: NCT03476980

Recruiting

Impella RP Flex with Smart Assist

for
Right Ventricular (RV) Dysfunction
Location: Portland OR, Puyallup WA, Spokane WA, Missoula MT,
Sponsor: Abiomed Inc.

Sex: All

Age: 0+

Code: NCT06637644

Recruiting

Treatment With Endovascular Intervention for STroke Patients With Existing Disability

for
Stroke, Stroke, Acute, Stroke, Ischemic
Location: Portland OR, Seattle WA, Palo Alto CA,
Sponsor: University of Cincinnati

Sex: All

Age: 18+

Code: NCT05911568

Recruiting

MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions

for
In-Stent Restenosis, Cardiovascular Diseases,
Location: Portland OR, Los Angeles CA, Gilbert AZ, Minneapolis MN,
Sponsor: Concept Medical Inc.

Sex: All

Age: 18 - 70+

Code: NCT05908331

Recruiting

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

for
Carcinoma, Transitional Cell, Urinary Bladder Neoplasms,
Location: Portland OR, San Francisco CA, Las Vegas NV,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT07218380

Phase3, Recruiting

Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma

for
Endometrial Carcinoma, Endometrial Clear Cell Adenocarcinoma,
Location: Portland OR, Seattle WA, Edmonds WA, Ontario OR,
Sponsor: National Cancer Institute (NCI)

Sex: Female

Age: 18+

Code: NCT05256225

Phase3, Recruiting

Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer

for
Astrocytoma, IDH-Mutant, Grade 3
Location: Portland OR, Seattle WA, Sacramento CA, Bakersfield CA,
Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 12+

Code: NCT07215910

Phase3, Recruiting

Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial

for
Metastatic Castration-Resistant Prostate Carcinoma,
Location: Portland OR, Seattle WA, Edmonds WA, Post Falls ID,
Sponsor: Alliance for Clinical Trials in Oncology

Sex: Male

Age: 18+

Code: NCT07200830

Phase3, Recruiting

Testing the Combination of Venetoclax and Rituximab, in Comparison to the Usual Treatment (Ibrutinib Plus Rituximab or Zanubrutinib Alone) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma

for
Lymphoplasmacytic Lymphoma, Waldenstrom Macroglobulinemia
Location: Portland OR, Issaquah WA, Seattle WA, Edmonds WA,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT04840602

Phase2, Recruiting

A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants With First-Line Advanced or Unresectable Hepatocellular Carcinoma (HCC) (ROSETTA HCC-206)

for
Hepatocellular Carcinoma (HCC)
Location: Portland OR, Nashville TN, Hackensack NJ
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT07291076

Phase1, Phase2, Recruiting

Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia

for
B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative,
Location: Portland OR, Nampa ID, Las Vegas NV, Duarte CA,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT03739814

Phase2, Recruiting

FORWARD CAD IDE Study

for
Coronary Arterial Disease (CAD)
Location: Portland OR, Seattle WA, Bellevue WA, San Francisco CA,
Sponsor: Shockwave Medical, Inc.

Sex: All

Age: 18+

Code: NCT06662500

Recruiting

Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2

for
Intracerebral Hemorrhage
Location: Portland OR, Vancouver, Sacramento CA, San Francisco CA,
Sponsor: Joseph Broderick, MD

Sex: All

Age: 18 - 70+

Code: NCT07227246

Phase3, Recruiting

Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)

for
Non-Small Cell Lung Cancer
Location: Portland OR, Reno NV, Calgary, Orange CA, Irvine CA,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT07100080

Phase2, Phase3, Recruiting

AGENT DCB STANCE: Safety and Effectiveness Study of AGENT Drug-Coated Balloon Compared to Standard of Care Percutaneous Coronary Intervention (PCI) Treatment for de Novo Coronary Lesions

for
Coronary Arterial Disease (CAD),
Location: Portland OR, Bellevue WA, San Francisco CA, Stanford CA,
Sponsor: Boston Scientific Corporation

Sex: All

Age: 18+

Code: NCT06959524

Recruiting